• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWWD:GR

151.2000 EUR 0.3000 0.20%

As of 06:45:02 ET on 09/02/2014.

Snapshot for DWS Biotech (DWWD)

Open: 152.7000 High - Low: 154.0700 - 151.1700 Primary Exchange: Frankfurt
Volume: 571 52-Week Range: 102.2800 - 154.0900 Beta vs NBI: 0.9535

ETF Chart for DWWD

No chart data available.
  • DWWD:GR 151.1700
  • 1D
  • 1M
  • 1Y
151.5000
Interactive DWWD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWWD

DWS Biotech is an open-end fund incorporated in Germany. The Fund's objective is capital growth. The Fund invests primarily in biotech equities worldwide. The Fund focuses on companies in the U.S. and the portfolio may also include selected pharmaceutical and medical equipment firms. The Fund's investment is oriented on the MSCI BioTecnology Select Index.

Inception Date: 1999-08-16 Telephone: Tel. 49-1803-10111011
Managers: NOUSHIN IRANI TURNER
Web Site: www.dws.de

Fundamentals for DWWD

NAV (on 2014-09-01) 151.9700
Assets (M) (on 2014-09-01) 321.5194
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -0.31
Average 52-Week % Premium -0.6534
Fund Leveraged N

Dividends for DWWD

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for DWWD

1-Month +17.22% 1-Year +39.50%
3-Month +24.18% 3-Year +44.81%
Year To Date +31.37% 5-Year +28.16%
Expense Ratio 1.70

Top Fund Holdings for DWWD

Filing Date: 05/30/2014
Name Position Value % of Total
Biogen Idec Inc 115,000 27,022,694 9.762%
Celgene Corp 450,000 25,333,534 9.152%
Gilead Sciences Inc 415,000 25,024,758 9.040%
Alexion Pharmaceuticals Inc 136,000 16,737,478 6.046%
Amgen Inc 174,000 14,828,311 5.357%
Vertex Pharmaceuticals Inc 228,250 12,209,173 4.411%
Regeneron Pharmaceuticals Inc 42,000 9,448,596 3.413%
Jazz Pharmaceuticals PLC 90,000 9,432,551 3.408%
BioMarin Pharmaceutical Inc 210,000 8,870,980 3.205%
Alkermes PLC 220,086 7,450,567 2.692%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil